A vaccine made from aging tumor cells slowed tumors in mice
Original title: Turning aging cells into a live vaccine: engineered senescent cancer cells with adjuvant celecoxib for immunotherapy
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done in mice.
The short version
A new kind of vaccine helped mice with tumors live longer, but it has not been tried in people.
What was studied. Researchers built a vaccine from aging tumor cells and a drug called celecoxib. They tested it in mice with melanoma and in mice with pancreatic tumors.
What they found. One dose slowed melanoma growth in the mice. Mice with melanoma that had spread to the brain lived longer. The vaccine also worked well against pancreatic tumors in mice.
What this means, and what it doesn't
What it could mean: This is early animal work. It points to one way to help the immune system find tumors. It may shape future studies. It does not change care today.
What it doesn't mean: This does not mean a new treatment is near. The work was done only in mice, not in people. Many things that help mice do not help people. It is not a cure, and no one knows yet if it is safe or useful for patients.
Source: bioRxiv (preprint), October 6, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.